Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,254 | 13,738 | 5,391 | 2,113 | 21,771 |
| Receivables | 886 | 1,054 | 1,795 | 1,257 | 10,439 |
| Inventories | 1,542 | 1,113 | 448 | 1,161 | 17,982 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 629 |
| Other current assets | 995 | 803 | 40,253 | 47,722 | 2,155 |
| TOTAL | $12,677 | $16,707 | $47,886 | $52,252 | $52,976 |
| Non-Current Assets | |||||
| PPE Net | 10,794 | 11,153 | 11,068 | 11,302 | 47,328 |
| Intangibles | 25,447 | 25,599 | 25,750 | 25,901 | 60,816 |
| Other Non-Current Assets | 979 | 947 | 44,102 | 48,571 | 6,164 |
| TOTAL | $37,221 | $37,699 | $80,920 | $85,774 | $114,309 |
| Total Assets | $49,897 | $54,406 | $128,806 | $138,026 | $167,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 15,810 |
| Accounts payable and accrued liabilities | 5,586 | 5,994 | 6,065 | 5,713 | 22,977 |
| Accrued Expenses | 1,683 | 2,285 | 1,386 | 2,109 | 3,430 |
| Other current liabilities | 1,815 | 1,468 | 3,506 | 1,632 | 2,935 |
| TOTAL | $9,228 | $9,949 | $50,435 | $48,015 | $47,135 |
| Non-Current Liabilities | |||||
| Long Term Debt | 150 | 172 | 48 | N/A | N/A |
| Other Non-Current Liabilities | 7,980 | 7,705 | 20,826 | 47,295 | 29,059 |
| TOTAL | $11,665 | $11,637 | $24,664 | $38,152 | $38,372 |
| Total Liabilities | $20,893 | $21,586 | $75,100 | $86,168 | $85,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129 | 112 | 106 | 102 | 88 |
| Common Shares | 170 | 16 | 155 | 138 | 130 |
| Retained earnings | -206,193 | -197,392 | -181,623 | -173,145 | -152,551 |
| Other shareholders' equity | -86 | -23 | 9,645 | 9,681 | 22,562 |
| TOTAL | $29,004 | $32,820 | $53,707 | $51,859 | $81,777 |
| Total Liabilities And Equity | $49,897 | $54,406 | $128,806 | $138,026 | $167,284 |